期刊文献+

注射用辅酶Ⅰ对老年患者瓣膜置换联合冠脉搭桥术后早期预后的影响 被引量:1

The effect of coenzyme Ⅰ for injection on the early prognosis of elderly patients after valve replacement combined with coronary artery bypass grafting
下载PDF
导出
摘要 目的探讨注射用辅酶I(NAD+)对老年患者行瓣膜置换联合冠脉搭桥术后早期预后的影响。方法选取2019年7月至2020年3月在武汉亚洲心脏病医院行瓣膜置换联合冠脉搭桥术的54例老年患者作为研究对象,采用随机数字表法分为研究组(27例)和对照组(27例),对照组采用常规治疗,研究组在常规治疗的基础上加用NAD+。比较两组患者手术前后左心室射血分数(LVEF)、N末端B型利钠肽前体(NT-proBNP)水平、心腔大小,并观察术后并发症的发生情况。结果术后7 d,研究组NT-proBNP指标低于对照组,差异有统计学意义(P<0.05),而两组的LVEF比较,差异无统计学意义(P>0.05);术后7 d,两组治疗后的左心房、左心室大小比较,差异无统计学意义(P>0.05);术后两组无死亡病例,无二次开胸;在术后其他并发症上,研究组出现心房颤动4例(14.81%),胸腔积液18例(66.67%),对照组出现心房颤动7例(25.92%),胸腔积液23例(85.18%)。研究组术后并发症的发生率低于对照组,但差异无统计学意义(P>0.05)。结论瓣膜置换联合冠脉搭桥术后使用NAD+对老年患者的早期预后有积极作用。 Objective To investigate the effect of coenzyme I for injection(NAD+)on the early prognosis of elderly patients undergoing valve replacement combined with coronary artery bypass grafting.Methods A total of 54 elderly patients who underwent valve replacement combined with coronary artery bypass surgery at Wuhan Asia Heart Hospital from July 2019 to March 2020 were selected as the research objects and divided into the study group(27 cases)and the control group(27 cases)by random number table method.The control group received conventional treatment,and the study group received NAD+on the basis of conventional treatment.The left ventricular ejection fraction(LVEF),N-terminal pro-B type natriuretic peptide(NT-proBNP)levels,and the size of the heart cavity were compared between the two groups of patients before and after surgery.The occurrence of postoperative complications was observed.Results 7 days after operation,the NT-proBNP in the study group was lower than that in the control group,with a statistically significant difference(P<0.05).While,there was no significant difference in LVEF between the two groups 7 days after operation(P>0.05).7 days after operation,there were no significant differences in the size of left atrium and left ventricle between the two groups(P>0.05).There were no death or second thoracotomy in the two groups after operation.In terms of other postoperative complications,atrial fibrillation occurred in 4 cases(14.81%)and pleural effusion in 18 cases(66.67%)in the study group,while atrial fibrillation occurred in 7 cases(25.92%)and pleural effusion in 23 cases(85.18%)in the control group.The incidence of postoperative complications in the study group was lower than that in the control group,but the difference was not statistically significant(P>0.05).Conclusion The use of NAD+after valve replacement combined with coronary artery bypass surgery has a positive effect on the early prognosis of elderly patients.
作者 张文 周武 阮新龙 周翔 张迎红 卢宏彪 ZHANG Wen;ZHOU Wu;RUAN Xinlong;ZHOU Xiang;ZHANG Yinghong;LU Hongbiao(Department of Cardiac Surgery,Wuhan Asia Heart Hospital,Hubei Province,Wuhan430022,China;School of Medicine,Wuhan University of Science and Technology,Hubei Province,Wuhan430062,China)
出处 《中国当代医药》 CAS 2022年第25期81-84,共4页 China Modern Medicine
关键词 NAD+ 心脏瓣膜置换术 冠脉搭桥术 早期预后 Coenzyme I for injection Heart valve replacement surgery Coronary artery bypass surgery Early prognosis
  • 相关文献

参考文献9

二级参考文献73

  • 1韩雅玲.中国经皮冠状动脉介入治疗指南2012(简本)[J].中国医学前沿杂志(电子版),2012,4(12):50-59. 被引量:133
  • 2Chaitanya Borde,Purushottam Kand,Sandip Basu.Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?[J].World Journal of Radiology,2012,4(5):220-223. 被引量:9
  • 3刘以民.高效液相色谱法测定肌苷注射液有关物质[J].医药导报,2006,25(11):1202-1202. 被引量:5
  • 4宋晶.三磷酸腺苷二钠、注射用辅酶A、维生素C联用纠正血透患者炎症状态的临床观察[J].中国基层医药,2007,14(7):1204-1206. 被引量:1
  • 5Bonow RO,Carabello BA,Chatterjee K. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologist[J].Journal of the America College of Cardiology,2008,(13):e1-e142.
  • 6Hillis LD,Smith PK,Anderson JL. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons[K].Journal of the America College of Cardiology,2011,(24):e123-e210.
  • 7Levine GN,Bates ER,Blankenship JC. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J].Journal of the America College of Cardiology,2011,(24):e44-e122.
  • 8Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology(ESC),European Association for Cardio-Thoracic Surgery(EACTS),Vahanian A. Guidelines on the management of valvular heart disease(version 2012)[J].EUROPEAN HEART JOURNAL,2012,(19):2451-2496.
  • 9Shahian DM, O'Brien SM, Filardo G, et al. The society of thoracic surgeons 2008 cardiac surgery risk models : valve plus coronary artery bypass grafting surgery [ J ]. Ann Thorac Surg, 2009,88 ( 1 Suppl) : $43-62. doi: 10. lO16/j, athoracsur. 2009.05. 055.
  • 10Fukui T, Bando K, Tanaka S, et al. Early and mid-term outcomes of combined aortic valve replacement and coronary artery bypass grafting in elderly patients [ J ]. Eur J Cardiothorac Surg,2014,45 ( 2 ) : 335- 340. doi : 10. 1093/ejcts/ezt242.

共引文献262

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部